Comparison of the effects of cimetidine and ranitidine on the pharmacokinetics of disopyramide in man.
The widely prescribed antiulcer agents cimetidine and ranitidine have the potential to affect the absorption, metabolism or renal excretion of disopyramide. This study investigated the effect of a single oral dose of cimetidine or ranitidine on the pharmacokinetics of disopyramide and mono-N-dealkyldisopyramide in six healthy volunteers. The treatment was conducted in a randomized cross-over design. Serum levels and urinary recoveries of disopyramide and mono-N-dealkyldisopyramide were assayed by HPLC. Cimetidine significantly elevated the maximum plasma concentration of disopyramide, the area under the plasma concentration-time curve and the total amount of disopyramide excreted unchanged in the urine, but the serum profile of mono-N-dealkyldisopyramide was not significantly affected. The effects of ranitidine on the pharmacokinetics of disopyramide and mono-N-dealkyldisopyramide were not significant. The interaction between cimetidine and disopyramide occurred mainly at the site of absorption. The results indicate that cimetidine, but not ranitidine, significantly increased the absorption of orally administered disopyramide.
Jou
M J
MJ
China Medical College Peikang Hospital, Peikang, Yun Lin, Taiwan, R.O.C.
Huang
S C
SC
Kiang
F M
FM
Lai
M Y
MY
Chao
P D
PD
D000284:Administration, Oral; D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000493:pharmacokinetics*; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D019540:Area Under Curve; D002927:Cimetidine / Q000494:pharmacology*; D018592:Cross-Over Studies; D004206:Disopyramide / Q000097:blood / Q000493:pharmacokinetics*; D004347:Drug Interactions; D006207:Half-Life; D006801:Humans; D008297:Male; D011899:Ranitidine / Q000494:pharmacology*
D000889:Anti-Arrhythmia Agents; D000897:Anti-Ulcer Agents; D002927:Cimetidine; D011899:Ranitidine; D004206:Disopyramide